Ghaziabad Online

Cardiac Mapping Market Share, Trends, Demand to Reach USD 2.66 Billion By 2027 at a CAGR of 8.5%.

 Breaking News
  • No posts were found

Cardiac Mapping Market Share, Trends, Demand to Reach USD 2.66 Billion By 2027 at a CAGR of 8.5%.

April 19
19:27 2021
Cardiac Mapping Market Share, Trends, Demand to Reach USD 2.66 Billion By 2027 at a CAGR of 8.5%.

Cardiac Mapping Market
Cardiac Mapping Market Size – USD 1.37 Billion in 2019, Market Growth – CAGR of 8.5%, Market Trends– Innovative devices are being introduced in the market by new entrants to establish themselves in the market.

According to the current analysis of Reports and Data, the global Cardiac Mapping Market was valued at USD 1.37 billion in 2019 and is expected to reach USD 2.66 billion by the year 2027, at a CAGR of 8.5%. Cardiac mapping is the development of detection of the temporal and spatial divisions of myocardial electrical potentials during a heart rhythm.

Cardiac mapping is broadly useful to identify heart issues such as arrythmia which is a very common heart disorder and is growing across the world. According to the estimations provided by the Centers for Disease Control and Prevention (CDC), around 2 percent of people younger than 65 years old are expected to suffer from atrial fibrillation while about 9 percentage of people aged 65 and older already have the disorder. The rising prevalence of such heart conditions is expected to the fuel the market in the future. Furthermore, the rising number of innovative devices introduced by various key players is expected to dive the cardiac mapping industry. The growing number of certified and experienced cardiologists in the developing economies is also a primary factor driving the market.

COVID-19 Impact:

The outbreak of the COVID-19 has resulted in more than a million deaths. The pandemic has impacted almost every industry and sector. There will also be a substantial change in the product pipeline, and the overall supply chain as macroeconomic shifts take place. As a result of the outburst, government authorities are increasingly concerned about the health and safety of citizens and healthcare workers. Moreover, the regulatory bodies and governments of various countries have issued numerous safety regulations of all sorts. To raise safety and health awareness, multiple organizations like the World Health Organization (WHO) and government health agencies are continuously guiding combating health diseases. The government initiatives are expected to provide traction to the market in the near future, considering the aftermath.  The medical sector will be at the receiving end of many investments an intervention from various sources. Once the COVID-19 cases start decreasing, the treatment of other chronic diseases will be back in the priority. These factors indicate that there will be prospects for Cardiac Mapping market in the future.

Various new entrants in the industry are known to have invested in the research and development to introduce innovative products to establish themselves in the market competition. Furthermore, the increasing geriatric population which is expected to be immensely to prone to chronic disorders including cardiac disorders, diabetes and others could lead the cardiac mapping industry towards growth. The rising funds and grants by the government and various other institutions is also a major driver for the market. Such funds and grants could lead to various new technological advancements that will develop the healthcare sector leading to better treatments. The lack of awareness about cardiac mapping in developing regions could be a primary factor that may hinder the market growth. Furthermore, the high cost of such systems and complex process associated with the same may also be some major restraints for the market.

Get a sample of the report @

 Further key findings from the report suggest

  • Increasing merger and acquisitions are expected to drive he market growth in future. For instance, in 2019, Acutuc medical entered into a collaboration with Peerbridge health. The merger facilitates use of AcQMap system in combination with Peerbridge Cor, an ECG product that detects different types of arrythmias.
  • In January 2019, Abbott received and FDA approval for its TactiCath catheter, which is capable of implying 3D mapping and can be significantly used to treat atrial fibrillation. Such approval for innovative devices could fuel the market extensively.
  • In September 2019, a cardiovascular tech developer Ablacon Inc. announced that they released an updated version of their existing technology under the company’s CE mark. Ablamap uses a novel and proprietary algorithm, operated by artificial intelligence, to visualize the flow of electrical activity within the heart. Once visualized, the Electrographic Flow map can be used to guide the application of ablation therapy to target potential sources of atrial fibrillation        
  • Various key players have launched their products in different regions to expand their sales. For instance, in November 2019, a cardiology devices developer, Baylis Medical launched its 2 French (2F) EPstar fixed electrophysiology catheter in the United States.
  • Key participants in the market Abbott, Boston Scientific Corporation, Medtronic, EP Solutions SA, Acutus Medical, Biosense Webster, Koninklijke Philips N.V., Epmap-System, MicroPort Scientific Corporation and CoreMap

For the purpose of this report, Reports and Data has segmented the Cardiac Mapping Market on the basis of technology, application, end use and region:

Technology Outlook (Revenue in Million USD; 2017–2027)

  • Contact Cardiac Mapping
    • Basket Catheter Mapping
    • Electroanatomical mapping
    • Real-time Positional Management (RPM) EP System
    • Traditional Endocardial Catheter Mapping            
  • Non- Contact Cardiac Mapping            

Application Outlook (Revenue in Million USD; 2017–2027)

  • Atrial Fibrillation
  • Atrial flutter
  • AV-nodal reentrant tachycardia (AVNRT)
  • Others

End-use Outlook (Revenue in Million USD; 2017–2027)

  • Hospitals
  • Clinics
  • Diagnostic and Imaging Centers
  • Others

Regional Outlook (Revenue in Million USD; 2017–2027)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Request customization of the report @

Table of Contents

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique

Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2017-2027

Chapter 3. Indicative Metrics
    3.1. Macro-Economic Indicators
          3.1.1. Rising technological advancements
          3.1.2. Increasing funds and grants for research and development

Chapter 4. COVID 19 impact assessment

    4.1. Cardiac Mapping Industry Outlook
    4.2. Rising Demand for Cardiac Mapping market due to COVID-19 pandemic
    4.3. Supply chain stabilization
 Supply scenario
 Demand scenario
    4.4. Upcoming strategies required to combat the current situation
    4.5. Alternative availability for suppliers
    4.6. No-contact methodologies in the supply chain
          4.6.1. Customer mapping

Chapter 5. Global Cardiac Mapping Market Segmentation & Impact Analysis

Chapter 6. Global Cardiac Mapping Market by Technology Insights & Trends

Chapter 7. Global Cardiac Mapping Market, Application Insights & Trends

Chapter 8. Global Cardiac Mapping Market, by End Use Insights & Trends

Chapter 9. Global Cardiac Mapping Market Regional Outlook

Chapter 10. Competitive Landscape

Chapter 11. Company Profiles
    11.1. Abbott
          11.1.1. Company Overview
          11.1.2. Financial Insights
          11.1.3. Products Offered
          11.1.4. Strategic Initiatives
    11.2. Boston Scientific Corporation
          11.2.1. Company Overview
          11.2.2. Financial Insights
          11.2.3. Products Offered
          11.2.4. Strategic Initiatives
    11.3. Medtronic
          11.3.1. Company Overview
          11.3.2. Financial Insights
          11.3.3. Products Offered
          11.3.4. Strategic Initiatives
    11.4. EP Solutions SA
          11.4.1. Company Overview
          11.4.2. Financial Insights
          11.4.3. Products Offered
          11.4.4. Strategic Initiatives
    11.5. Acutus Medical
          11.5.1. Company Overview
          11.5.2. Financial Insights
          11.5.3. Products Offered
          11.5.4. Strategic Initiatives
    11.6. Biosense Webster
          11.6.1. Company Overview
          11.6.2. Financial Insights
          11.6.3. Products Offered
          11.6.4. Strategic Initiatives
    11.7. Koninklijke Philips N.V.
          11.7.1. Company Overview
          11.7.2. Financial Insights
          11.7.3. Products Offered
          11.7.4. Strategic Initiatives
    11.8. Epmap-System
          11.8.1. Company Overview
          11.8.2. Financial Insights
          11.8.3. Products Offered
          11.8.4. Strategic Initiatives
 11.9. MicroPort Scientific Corporation
          11.9.1. Company Overview
          11.9.2. Financial Insights
          11.9.3. Products Offered
          11.9.4. Strategic Initiatives
    11.10. CoreMap
          11.10.1. Company Overview
          11.10.2. Financial Insights
          11.10.3. Products Offered
          11.10.4. Strategic Initiatives


Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States

Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5